Volume 116, Issue 10 pp. 888-895

Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer

AXEL GLAESSGEN

AXEL GLAESSGEN

Departments of Oncology-Pathology, Karolinska Institutet

Search for more papers by this author
SARA JONMARKER

SARA JONMARKER

Departments of Oncology-Pathology, Karolinska Institutet

Search for more papers by this author
ANNA LINDBERG

ANNA LINDBERG

Departments of Oncology-Pathology, Karolinska Institutet

Search for more papers by this author
BO NILSSON

BO NILSSON

Departments of Oncology-Pathology, Karolinska Institutet

Search for more papers by this author
ROLF LEWENSOHN

ROLF LEWENSOHN

Departments of Oncology-Pathology, Karolinska Institutet

Search for more papers by this author
PETER EKMAN

PETER EKMAN

Department of Urology, Karolinska University Hospital, Stockholm, Sweden

Search for more papers by this author
ALEXANDER VALDMAN

ALEXANDER VALDMAN

Departments of Oncology-Pathology, Karolinska Institutet

Search for more papers by this author
LARS EGEVAD

Corresponding Author

LARS EGEVAD

International Agency for Research on Cancer, Lyon, France

Lars Egevad, International Agency for Research on Cancer (IARC), World Health Organization (WHO), 150, Cours Albert Thomas, 69372 Lyon Cedex 08, France. e-mail: [email protected]Search for more papers by this author
First published: 18 December 2008
Citations: 58

Received 8 January 2008.

Accepted 10 April 2008.

Abstract

Heat shock proteins (HSPs) protect cells against stress-associated injury and are overexpressed in several malignant tumors. We aimed to investigate their value as prognostic markers in prostate cancer. A tissue microarray (TMA) was constructed of 289 prostate cancers from radical prostatectomy (RP) specimens with median follow-up of 48.9 months. Slides were immunostained for HSP27, HSP60 and HSP70. Intensity and extent of immunoreactivity (IR) and their product (IRp) was evaluated by two observers. The IRp of HSP27 and HSP60, but not of HSP70, significantly predicted biochemical recurrence (p=0.014, 0.034 and 0.160, respectively). Recurrence-free survival in patients with strong HSP27 and HSP60 staining was shorter than in those with weak expression (p=0.019 and 0.001, respectively). IRp of HSP27 and HSP60 correlated with Gleason score (p<0.01). HSP60 was an independent predictor of biochemical recurrence in multivariate analysis, including extraprostatic extension, margin status, seminal vesicle invasion and Gleason score. Weighted kappa for interobserver agreement of HSP27, HSP60 and HSP70 IR was 0.613–0.823 for intensity and 0.584–0.719 for IRp, but only 0.036–0.244 for extent, raising the question whether staining extent should be estimated on TMA. We conclude that HSP27 and HSP60 are predictors of biochemical recurrence after RP.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.